Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1968 Sep;109(3):219–223.

Acute promyelocytic leukemia with hypofibrinogenemia.

W C Laws, R A Bohannon, A J Robinson, P M Aggeler
PMCID: PMC1503209  PMID: 5245524

Full text

PDF
219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. J Clin Invest. 1962 Apr;41:917–934. doi: 10.1172/JCI104547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  3. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  4. BACHMANN F., DUCKERT F., KOLLER F. The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh. 1958 May 1;2(1-2):24–38. [PubMed] [Google Scholar]
  5. BAKER W. G., BANG N. U., NACHMAN R. L., RAAFAT F., HOROWITZ H. I. HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING. Ann Intern Med. 1964 Jul;61:116–123. doi: 10.7326/0003-4819-61-1-116. [DOI] [PubMed] [Google Scholar]
  6. BERNARD J., LASNERET J., CHOME J., LEVY J. P., BOIRON M. A CYTOLOGICAL AND HISTOLOGICAL STUDY OF ACUTE PREMYELOCYTIC LEUKAEMIA. J Clin Pathol. 1963 Jul;16:319–324. doi: 10.1136/jcp.16.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BORCHGREVINK C. F., POOL J. G., STORMORKEN H. A new assay for factor V (proaccelerin-accelerin) using Russell's viper venom. J Lab Clin Med. 1960 Apr;55:625–632. [PubMed] [Google Scholar]
  8. Ben-Zeev D., Schwartz S. O., Friedman I. A. Promyelocytic-myelocytic leukemia as a terminal manifestation of chronic granulocytic leukemia. Report of a case. Blood. 1966 Jun;27(6):863–870. [PubMed] [Google Scholar]
  9. CROIZAT P., FAVRE-GILLY J. Les aspects du syndrome hémorragique des leucémies; à propos de 12 cas de thrombocytopénie et d'un cas de fibrinopénie. Sang. 1949;20(7):417–421. [PubMed] [Google Scholar]
  10. DIDISHEIM P., TROMBOLD J. S., VANDERVOORT L. E., MIBASHAN R. S. ACUTE PROMYELOCYTIC LEUKEMIA WITH FIBRINOGEN AND FACTOR V DEFICIENCIES. Blood. 1964 Jun;23:717–728. [PubMed] [Google Scholar]
  11. FLETCHER A. P., ALKJAERSIG N., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest. 1962 Apr;41:896–916. doi: 10.1172/JCI104546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HILLESTAD L. K. Acute promyelocytic leukemia. Acta Med Scand. 1957 Nov 29;159(3):189–194. [PubMed] [Google Scholar]
  13. Merskey C., Johnson A. J., Kleiner G. J., Wohl H. The defibrination syndrome: clinical features and laboratory diagnosis. Br J Haematol. 1967 Jul;13(4):528–549. doi: 10.1111/j.1365-2141.1967.tb00762.x. [DOI] [PubMed] [Google Scholar]
  14. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  15. NUSSENZWEIG V., SELIGMANN M., GRABAR P. [The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities]. Ann Inst Pasteur (Paris) 1961 Apr;100:490–508. [PubMed] [Google Scholar]
  16. NUSSENZWEIG V., SELIGMANN M., PELMONT J., GRABAR P. [The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties]. Ann Inst Pasteur (Paris) 1961 Mar;100:377–389. [PubMed] [Google Scholar]
  17. NUSSENZWEIG V., SELIGMANN M. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages]. Nouv Rev Fr Hematol. 1960 Nov-Dec;15:451–466. [PubMed] [Google Scholar]
  18. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  19. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PARKER M. G., LOWNEY J. F. ACUTE PROMYELOCYTIC LEUKEMIA. CASE REPORTS. Mo Med. 1965 May;62:374–378. [PubMed] [Google Scholar]
  21. POOL J. G., ROBINSON J. Assay of plasma antihaemophilic globulin (AHG). Br J Haematol. 1959 Jan;5(1):17–23. doi: 10.1111/j.1365-2141.1959.tb04009.x. [DOI] [PubMed] [Google Scholar]
  22. Pittman G. R., Senhauser D. A., Lowney J. F. Acute promyelocytic leukemia. A report of 3 autopsied cases. Am J Clin Pathol. 1966 Aug;46(2):214–220. doi: 10.1093/ajcp/46.2.214. [DOI] [PubMed] [Google Scholar]
  23. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  24. ROSENTHAL R. L. Acute promyelocytic leukemia associated with hypofibrinogenemia. Blood. 1963 Apr;21:495–508. [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES